Total number | 19 | 21 | |
Male (n (%)) | 5 (26.3) | 7 (33.3) | |
Female (n (%)) | 14 (73.7) | 14 (66.6) | |
Age (years) |
Mean (SD) | 54.4 (14.9) | 51.8 (13.6) | NS |
Duration of disease (years) |
Mean (SD) | 8.8 (7.1) | 5.4 (5.4) | NS |
Type of disease (n (%)) |
SMS | 11 (57.9) | 10 (47.6) | |
PERM | 7 (36.8) | 6 (28.6) | |
SLS | 1 (5.3) | 2 (9.5) | |
pSMS | 0 (0.0) | 3 (14.3) | |
Antibody status (n (%)) |
AntiGAD positive | 16 (84.2) | 13 (61.9) | |
AntiAMP positive | 0 (0.0) | 2 (9.5) | |
AntiGAD/AMP negative | 3 (15.8) | 6 (28.6) | |
Exaggerated startle response (n (%)) | 16 (84.2) | 11 (52.4) | < 0.05 |
Psychiatric comorbidity present (n (%)) | 11 (57.9) | 8 (38.1) | NS |
Significant life event before onset (n (%)) | 11 (57.9) | 8 (44.4†) | NS |
Initial psychogenic misdiagnosis (n (%)) | 15 (78.9) | 8 (38.1) | < 0.02 |